$Intravenous Immunoglobulins for Refractory Status Epilepticus, Part I: A Scoping Systematic Review of the Adult Literature$

Intravenous Immunoglobulins for Refractory Status Epilepticus, Part I: A Scoping Systematic Review of the Adult Literature

Highlights • A scoping systematic review on IVIG for adult RSE was performed. • 24 original articles met the inclusion/exclusion criteria, with 33 patients were treated. • 15 of 33 patients (45.4%) responded to IVIG therapy. • 1 (3.0%) and 14 (42.4%) patients displayed partial and complete responses...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Seizure (London, England) England), 2017-02, Vol.45, p.172-180
Hauptverfasser:	Zeiler, F.A, Matuszczak, M, Teitelbaum, J, Kazina, C.J, Gillman, L.M
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Databases, Factual - statistics & numerical data Drug Resistant Epilepsy - therapy Humans Immunoglobulin Immunoglobulins, Intravenous - therapeutic use Immunologic Factors - therapeutic use Intravenous immunoglobulins IVIG Neurology Refractory status epilepticus Status epilepticus Status Epilepticus - therapy
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Highlights • A scoping systematic review on IVIG for adult RSE was performed. • 24 original articles met the inclusion/exclusion criteria, with 33 patients were treated. • 15 of 33 patients (45.4%) responded to IVIG therapy. • 1 (3.0%) and 14 (42.4%) patients displayed partial and complete responses respectively. • There is Oxford level 4, GRADE D evidence for IVIG in adult RSE.
ISSN:	1059-1311 1532-2688
DOI:	10.1016/j.seizure.2016.12.017